VAQUET SHOMO-BROWN: Open Payments
NPI 1124226865 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 22 payments from 10 companies in 2025. Trend: 2023 $1,308 · 2024 $2,605 · 2025 $2,312
Food & beverage: $2,312
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $583 |
| ABBVIE INC. | 5 | $475 |
| Axsome Therapeutics, Inc. | 2 | $249 |
| Janssen Pharmaceuticals, Inc | 2 | $229 |
| Novo Nordisk Inc | 2 | $197 |
| GENZYME CORPORATION | 1 | $134 |
| Hologic Sales and Service, LLC | 1 | $131 |
| ARGENX US, INC. | 1 | $123 |
| Alkermes, Inc. | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 1 | $91 |
Products named: COBENFY, VRAYLAR, Auvelity, INVEGA SUSTENNA, APTIMA, VYVGART, MAVYRET, LYBALVI.
Industry payments across OH — which companies pay providers there.
